Divis Laboratories Share Price Graph And News

Divi’s Laboratories Ltd. is an India based manufacturer company of Active Pharmaceutical Ingredients (APIs) and Intermediates. This company is engaged in the manufacture of leading generic compounds, Nutraceutical ingredients and custom synthesis of Active Pharmaceutical Ingredients (APIs) and intermediates for global innovator companies. Divi’s Laboratories Ltd is among the largest pharmaceutical companies in India with a portfolio of 120 products across diverse therapeutic areas. This company has 4 manufacturing facilities and market presence across several countries. The 1st facility is located at village Lingojigudem in Yadadri Bhuvanagiri District near Hyderabad (Telangana) comprises 11 multipurpose production blocks with finished product areas for APIs. A 2nd manufacturing unit is an export-oriented unit located at village Chippada, Bheemunipatnam Mandal, about 30 KM from the port city of Visakhapatnam (Andhra Pradesh) on the east coast situated on a 100-acre site. The 3rd facility is located at village Chippda situated on a sprawling 267-acre site and is a Special Economic Zone (SEZ) Unit in Pharma Sector. The 4th facility is located at the company’s Pharma SEZ at village Chippada. The article main discussion point will be on Divis Laboratories Share Price Graph And News.

About the company –

This is the first stage of the article Divi’s Laboratories Share Price Graph And News. Divi’s Laboratories Ltd has been established for more than 28 years in Hyderabad, India with two manufacturing units and is among the top pharmaceuticals companies in India. This company is recognized as a ‘Reliable Supplier of generic APIs (Active pharmaceuticals ingredients)’ and a trustworthy ‘Custom Manufacturer’ to Big Pharma and also is among the top API manufactures in the world. Divi’s Laboratories Ltd is the leading manufacturer of APIs(Active pharmaceuticals ingredients), Intermediates and Registered starting materials offering high-quality products with the highest level of compliance and integrity to over 95 countries. This company recently reaches the milestone of being one among the top 3 API manufacturers in the world and one among the top API companies in Hyderabad
11,000 highly trained professionals across departments and 350 scientists at Divi’s work together to bring world-class products to customers. Divi’s Laboratories Ltd is a Public limited company listed on the Indian stock exchange with revenue of INR 3949 crores (~$620M) for the year 2017-18. Advanced manufacturing facilities of this company both in Hyderabad and Vizag. Also, manufacturing facilities have been inspected multiple times by FDA, EU GMP (UK, Slovenia, German, Irish authorities), HEALTH CANADA, TGA, ANVISA, COFEPRIS, PMDA and MFDS health authorities.

Divis Laboratories Share Price Graph

Company summary –

After Divis Laboratories Share Price, we will move on to the company summary. Divi’s Laboratories Ltd was established in the year 1990. Divi’s Research Center (DRC) with Research and Development as their prime fundamental. This company successfully developed several commercial processes for intermediates and bulk actives and supplies to manufacturing majors during the year 1991-93. In the year 1994, they changed their name to Divi’s Laboratories Ltd to reflect their growing area of operations. This company started operations in its manufacturing facility (Unit I) at Choutuppal near Hyderabad in the year 1995. In the year 1997, Divi’s Laboratories Ltd was certified as ISO-9002 compliant by SGS-Yarsley of U.K.

Divi’s Laboratories Ltd has two World class manufacturing units with a combined capacity of 12000 m3 and one of this being the World’s largest API manufacturing facility. This company also has 350 scientists working in three Ru0026amp;D centers across functions. Divi’s Laboratories Ltd quality control testing and validation labs are fitted with state of the art analytical equipment and testing facilities. This company has 11,000 employees across 3 countries form a robust workforce. Divi’s Laboratories Ltd has 2 large cGMP API manufacturing units producing 100s or 1000s of Tons of APIs that are exported to more than 95 countries. More than 1700 employees of this company are working in Quality Assurance and Quality Control functions form the backbone of our Quality System.

Registered Address –

Address : 1-72/23(p)/divis/303, Divi Towers,
Cyber Hills, Gachibowli,
Hyderabad, Telangana – 500032.
Phone: 040 2378 6300
Fax : 040 2378 6460
Email: [email protected]
Website: www.divislaboratories.com

Registrars –

Karvy Selenium Tower B,
Plot 31-32, Gachibowli,
Financial District, Nanakramguda,
Hyderabad – 500032.
Phone: 91-040-67161500
Fax: 91-040-23001153
Email: [email protected]
Website: www.karvy.com

Company financials :

Company financials are necessary to state Divis Laboratories Share Price graph and news. Divi’s Laboratories Ltd. key Products or Revenue Segments include Active Pharma Ingredients which contributed Rs.3722.20 Crore to Sales Value 97.00 % of Total Sales. Export Incentives of this company which contributed Rs.65.18 Crore to Sales Value 1.69 % of Total Sales. Divi’s Laboratories Ltd’s Contract Fees which contributed Rs.30.99 Crore to Sales Value 0.80 % of Total Sales. A scrap of this company which contributed Rs.18.86 Crore to Sales Value 0.49 % of Total Sales for the year ending 31st March 2018.

According to the latest report, the company’s market cap stands at the level of 44,773.93. The company’s industry P/E was at the level of 28.68. Price/Book value 7.56.

divi's laboratories profit and loss sheet

For the quarter ended 31st December 2018, Divi’s Laboratories Ltd. has reported a Standalone sales of Rs.1342.92 Crore, up 4.51 % from last quarter Sales of Rs.1285.00 Crore and up 29.39 % from last year same quarter Sales of Rs.1037.88 Crore. This company has reported a net profit after tax of Rs.379.49 Crore in the latest quarter.

The Board of Directors of the company :

  • Murali K Divi is the Chairman and Managing Director of this company.
  • Kiran S Divi is the Whole Time Director of the company.
  • N V Ramana is an Executive Director of this company.
  • G Suresh Kumar is an Independent Director of the company.
  • Ramesh B V Nimmagadda is the Independent Director of this company.
  • Madhusudana Rao Divi is one of the Whole Time Director of the company.
  • Nilima Motaparti is the Whole Time Director of this company.
  • K V K Seshavataram is one of the Independent Director of the company.
  • R Ranga Rao is the Independent Director of this company.
  • S Ganapathy is an Independent Director of the company.

News of the company :

This is the last stage of the content Divis Laboratories Share Price. In the dated 28th February 2019, reported that the Nifty Pharma index was trading 0.62 percent up at 8920.75. The Nifty Pharma index was trading 0.76 percent up at 8838.90 in 25th February 2019. In the dated 27th February 2019, reported that the Nifty Pharma index was trading 1.61 percent up at 8971.60. Divi’s Laboratories Ltd said the raids were conducted by the officials of Income-Tax Department under Section 132 of the Income-Tax Act in 19th February 2019.

Besides the Divis Laboratories Share Price, to get more information on other companies, visit our Stock Technical page.

Scroll to top